OMRELBA
Pharmaceutical preparation for the treatment of infection-related diseases and other conditions associated with a dysregulated immune system, namely, an immunomodulator for the treatment of suspected organ dysfunction or failure in patients with necrotizing soft tissue infections (NSTI) or NSTI with sepsis
Abandoned · November 25, 2020 · 90341948 ·